In vitro pharmacokinetics and drug–drug interaction studies (DDI) play a central role in drug discovery projects by guiding chemical optimization. Our assay platform covers all routine in vitro PK and DDI screening assays for small molecule drugs using state-of-the-art technology, and we provide valuable input for drug discovery projects in all stages. Focusing on your requirements, we support your research with tailor-made solutions, medium-throughput manual assays, or fully automated high-throughput screening assays on robotic systems. Furthermore, our experienced, PhD-level scientists have a strong understanding of the interpretation of the results, integrating these into the project context, and setting up structure–property relationships. We can accommodate your needs, whether for screening services or the design, performance, and evaluation of screening cascades.
Our in vitro compound profiling services include assays for